Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KID Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA529490
Description
Recommended positive controls: IMR-32, SK-N-AS. Predicted reactivity: Mouse (88%), Rat (86%), Pig (93%), Chimpanzee (99%), Bovine (92%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The protein encoded by this gene is a member of kinesin-like protein family. This family of proteins are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. The C-terminal half of this protein has been shown to bind DNA. Studies with the Xenopus homolog suggests its essential role in metaphase chromosome alignment and maintenance.
Specifications
KID | |
Polyclonal | |
Unconjugated | |
KIF22 | |
A-328A3.2; AU021460; C81217; Kid; Kif22; Kif22a; kinesin family member 22; kinesin family member 22A; kinesin-like 4; Kinesin-like DNA-binding protein; kinesin-like DNA-binding protein pseudogene; kinesin-like protein 4; Kinesin-like protein KIF22; KNSL4; OBP; OBP-1; OBP-2; origin of plasmid DNA replication-binding protein; oriP binding protein; SEMDJL2 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
293502, 3835 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q14807, Q5I0E8 | |
KIF22 | |
Recombinant fragment corresponding to a region within amino acids 256 and 527 of Human KIF22. | |
100 μL | |
Primary | |
Human, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction